Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director YERXA BENJAMIN R
Clearside Biomedical | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Clearside Biomedical | 10-Q: Quarterly report
Clearside Biomedical | 8-K: Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
Clearside Biomedical | ARS: Annual Report to Security Holders
Clearside Biomedical | DEFA14A: Others
Clearside Biomedical | DEF 14A: Definitive information statements
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Gibney Anthony S
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Gibney Anthony S
Clearside Biomedical | 3: Initial statement of beneficial ownership of securities-Director Gibney Anthony S
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Officer Chong Ngai Hang Victor
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Officer Chong Ngai Hang Victor
Clearside Biomedical | 3: Initial statement of beneficial ownership of securities-Officer Chong Ngai Hang Victor
Clearside Biomedical | 10-K: Annual report
Clearside Biomedical | 8-K: Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-10% Owner WHITMORE BRADFORD T
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 424B5: Prospectus
Clearside Biomedical | 8-K: Current report
No Data